Envarsus: Clinical Trials

9 trials of Envarsus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown, 1 active not recruiting, 1 enrolling by invitation. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 4, Unknown 2, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1

Follow Envarsus: new trials by email Literature Review of Envarsus trials Research Report on Envarsus

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
Tacrolimus Pill, Tacrolimus capsule - Immunosuppression
Phase 4Active not recruitingEdward Geissler3222024-03-092026-11-05
Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients
Prograf, Envarsus - Liver Transplant Rejection, Immune System Suppression
Phase 4Enrolling by invitationUniversity Health Network, Toronto402024-01-012024-12-11
Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
Tacrolimus, Immediate Release, Oral, Tacrolimus Extended Release Oral Tablet - Liver Transplantation, Immunosuppression
Phase 4RecruitingUniversity of British Columbia1242023-01-092024-01-02
Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy
Mycophenolate Mofetil, Tacrolimus - Autoimmune Hepatitis
Phase 4UnknownLeiden University Medical Center862022-01-192022-02-03
Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients
Tacrolimus Pill, Tacrolimus capsule - Prophylaxis Against Liver Transplant Rejection
Phase 4CompletedEdward Geissler2682020-12-232026-11-05
Envarsus Neurotoxicity Burden in Liver Transplant Patients
Envarsus, Tacrolimus Immediate release - Neurotoxicity, Liver Transplant; Complications
Phase 4CompletedMedical University of South Carolina302020-01-312025-03-30
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
Tacrolimus - Transplant;Failure,Kidney
Phase 4CompletedSentara Norfolk General Hospital462020-01-162024-02-29
Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients
Envarsus, IR Tacrolimus - Kidney Transplant; Complications, Toxicity
Phase 4CompletedUniversity of California, Davis642018-04-012025-04-08
AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation
ENVARSUS, Standard twice daily tacrolimus - Kidney Transplant Failure and Rejection
Phase 4UnknownUniversity Hospital Birmingham NHS Foundation Trust402017-04-012016-12-29

Conditions studied

Neurotoxicity Syndromes (3)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Hepatitis, Autoimmune (1)  ·  Rejection, Psychology (1)  ·  Tremor (1)

Sponsors

Edward Geissler (2)  ·  Leiden University Medical Center (1)  ·  Medical University of South Carolina (1)  ·  Sentara Norfolk General Hospital (1)  ·  University Health Network, Toronto (1)  ·  University Hospital Birmingham NHS Foundation Trust (1)  ·  University of British Columbia (1)  ·  University of California, Davis (1)

Countries

United States (3)  ·  Canada (2)  ·  Germany (2)  ·  Netherlands (1)

Top investigators

Adnan Sharif, MD (1)  ·  Bart van Hoek (1)  ·  Bernhard Banas, MD (1)  ·  Derek Dubay, MD (1)  ·  Hans J. Schlitt, MD (1)  ·  Jo-Ann Ford, RN (1)  ·  Ling-Xin Chen, MD (1)  ·  Nazia Selzner, MD (1)  ·  Thomas McCune, MD (1)  ·  Trana Hussaini, Pharm D (1)

Results publications

PMID 37170284, PMID 38233878, PMID 41089174

NIH funding

2023 (1)